US EditionTriSalus Life Sciences launches the TriNav FLX infusion system - Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
TriSalus Life Sciences launches the TriNav FLX infusion system - Interventional News
TriSalus Life Sciences has announced the launch of the TriNav FLX infusion system. The TriNav FLX infusion system retains the same trusted pressure-enabled drug delivery (PEDD) benefits as existing products but introduces an important advancement in design, states a recent company press release. The new system features twice the length of flexible material at the distal end, allowing for easier navigation through more tortuous vessels. Key featu…
TriSalus Life Sciences launches new infusion system
TriSalus Life Sciences (Nasdaq:TLSI) announced today that it launched its new TriNav FLX infusion system. TriNav FLX features enhanced trackability and significantly expands the company’s existing TriNav portfolio of products. It offers interventional radiologists more options to select the right product for the right patient, TriSalus said in a news release. According to TriSalus, the TriNav FLX infusion system retains its existing Pressure-Ena…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
